Sunscreen and Melanoma: Does Sun Protection Prevent CMM?
This paper critically examines the widely held assumption that sunscreen use effectively prevents cutaneous malignant melanoma (CMM). Drawing primarily on Planta's (2011) review published in the Journal of the American Board of Family Medicine, the paper surveys epidemiological data showing that CMM rates continue to rise despite increased sunscreen use, that CMM incidence is paradoxically higher in regions with less sun exposure and among indoor workers, and that standard SPF ratings do not account for UVA radiation — a known contributor to melanoma risk. The paper also evaluates the hypothesis that chronic, low-grade sun exposure may confer a protective tolerance, and concludes that current clinical messaging around sunscreen alone is insufficient and potentially misleading.
- Introduction: Questioning the Sunscreen Consensus: Mainstream sunscreen advice challenged by rising melanoma rates
- Epidemiological Paradoxes in CMM Distribution: CMM higher indoors and in low-sunlight regions
- UVA, UVB, and the Limits of SPF: SPF ratings miss UVA radiation linked to melanoma
- The Case for Chronic Low-Grade Sun Exposure: Regular mild sun exposure may protect against CMM
- Why Sunscreen Users May Face Higher Risk: False security leads to longer, riskier sun exposure
- Contradictory Evidence and Clinical Implications: Mixed evidence informs revised clinical sun-safety messaging
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- The paper opens with a bold, counterintuitive claim — that sunscreen may not prevent melanoma — and immediately backs it with epidemiological data, creating strong reader engagement and a clear argumentative through-line.
- It handles contradictory evidence honestly, acknowledging an Australian study that supports sunscreen use, which demonstrates intellectual fairness and strengthens overall credibility.
- The paper connects scientific findings to practical clinical advice, bridging research and real-world application in a way that is accessible to both medical and general audiences.
Key academic technique demonstrated
The paper exemplifies evidence-based critical analysis: rather than accepting a widely endorsed public health recommendation at face value, the author systematically interrogates the research base behind it. By presenting epidemiological anomalies (higher CMM rates in low-sun regions, among indoor workers, and among sunscreen users), the paper challenges assumptions and builds toward a nuanced revision of clinical messaging — a hallmark of evidence-based medicine writing.
Structure breakdown
The paper follows a problem-complication-resolution structure. It opens by establishing the mainstream consensus and immediately complicating it with contradictory data. Middle sections drill into the biological mechanisms (UVA vs. UVB) and behavioral factors (false security from sunscreen). The paper then introduces an alternative hypothesis (protective sun tolerance) before concluding with balanced clinical recommendations. This arc is well-suited to persuasive health sciences writing.
Introduction: Questioning the Sunscreen Consensus
The idea that sunscreen is an effective weapon against melanoma has become so commonly cited that it borders on cliché. Not only do primary care providers recommend wearing sunscreen with an SPF above 15 — magazines and popular media reinforce this advice as well. However, according to Planta (2011), evidence-based research does not support the idea that sunscreen protects against cutaneous malignant melanoma (CMM). In fact, although rates of sunscreen use have increased in recent years, rates of this particularly deadly form of skin cancer have continued to rise at approximately 3% per year (Planta, 2011).
There is also a correlation between sunblock use and a greater likelihood of developing sunburns, which itself elevates the risk of melanoma. Even children whose parents applied sunblock more regularly showed higher rather than lower rates of skin cancer, according to one Swedish study of children aged 5–7. The U.S. Environmental Protection Agency has concluded that "there is no evidence that sunscreens protect you from malignant melanoma" (Planta, 2011).
Epidemiological Paradoxes in CMM Distribution
Studies are contradictory regarding sunscreen efficacy in preventing skin cancer of all varieties. Some evidence suggests that sunblock may reduce the risk of squamous cell carcinoma but not basal cell carcinoma. More importantly, while there is convincing evidence that non-melanoma skin cancers are related to cumulative sun exposure, the same association with CMM is far less established. If CMM were related to cumulative sun exposure, outdoor workers would be expected to have a greater incidence than indoor workers — yet that is not the case (Planta, 2011).
In fact, CMM is increasing most rapidly among individuals who spend the majority of their time indoors and who receive three to nine times less solar UV radiation than those who work or recreate outdoors. As Planta (2011) notes, "there is a higher incidence of CMM among whites living in northern states such as Delaware, Vermont, and New Hampshire (>30 per 100,000), which enjoy less year-round sunlight and UV radiation than southern states such as Texas, Florida, Arizona, and New Mexico (<25 per 100,000). In California, whites living in San Francisco had a CMM incidence of 30.5 per 100,000, whereas those living in Los Angeles had an incidence of 24.9 per 100,000." These geographic patterns challenge the straightforward assumption that more sun equals more melanoma risk.
UVA, UVB, and the Limits of SPF
The rationale behind recommending sunblock rests on the fact that ultraviolet (UV) radiation is a recognized carcinogen, and sunblock is designed to filter it. Both UVA and UVB radiation are emitted by the sun, but because UVB was historically believed to be the primary cause of all skin cancers through direct DNA damage, early sunscreens were developed to block UVB with little or no protection against UVA. Critically, the sun protection factor (SPF) rating on sunscreen packaging refers exclusively to protection against UVB radiation and says nothing about UVA protection (Planta, 2011).
Recent evidence indicates that UVA also plays a significant role in melanoma development through "oxidative stress, free radical generation, and the degradation of vitamin D" (Planta, 2011). This is supported by elevated skin cancer rates among tanning bed users, even though artificial tanning light emits a higher ratio of UVA to UVB than natural sunlight. Some sunscreen ingredients — including benzophenones, titanium dioxide, and zinc oxide — offer greater UVA protection than conventional formulations. However, even the most effective UVA blocker, titanium dioxide, filters only 25% of UVA radiation (Planta, 2011), leaving a substantial gap in protection.
Reference
Planta, M. (2011). Sunscreen and melanoma: Is our prevention message correct? Journal of the American Board of Family Medicine, 24(6), 735–739. Retrieved from http://www.jabfm.org/content/24/6/735.full
Create your account
Always verify citation format against your institution’s current style guide requirements.